PONIARD PHARMACEUTICALS, INC. 4
4 · PONIARD PHARMACEUTICALS, INC. · Filed Jun 25, 2008
Insider Transaction Report
Form 4
BASSO ROBERT S
Director
Transactions
- Award
Stock Option (right to buy)
2008-06-24+15,000→ 15,000 totalExercise: $4.40Exp: 2018-06-24→ Poniard Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option becomes exercisable 50% after one year from date of grant and 100% after two years from date of grant.